| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.88 | 0.04 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.46 | 0.1 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.24 | 0.2 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.01 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.17 | 0.6 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.17 | 0.003 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.14 | 0.009 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.13 | 0.5 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.13 | 0.4 |